We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Liquid Rhinoplasty Offers a Non-Surgical Cosmetic Alternative

By HospiMedica International staff writers
Posted on 12 Mar 2020
Print article
Image: An example of liquid rhinoplasty (Photo courtesy of Dr. Ayad Harb)
Image: An example of liquid rhinoplasty (Photo courtesy of Dr. Ayad Harb)
Nonsurgical rhinoplasty using dermal fillers is a safe procedure with positive aesthetic results when performed by an experienced clinician, claims a new study.

Ayad Harb, FRCSPlast, a consultant plastic surgeon and world authority on liquid rhinoplasty, and Colin Brewster, MRes, of Queen Elizabeth Hospital (Gateshead, United Kingdom), conducted a study of nonsurgical rhinoplasty in 5,000 patients (mean age 27 years, mostly female), who were treated between March 2016 and January 2019 by Dr. Harb. Study parameters included patient demographics, indications, treatment details, and outcomes. Average procedure time was 12 minutes, with the average filler injected about 0.72 mL.

The most common patient complaint was a dorsal hump (44%), with about 20% of patients seeking to refine the results after a previous rhinoplasty surgery. Liquid rhinoplasty was also used to treat other patient concerns, such as drooping nasal tip (15%), lack of definition (almost nine percent), frontal asymmetry (seven percent) and bulbous tip (six percent). Hyaluronic acid was the preferred filler due to its reversibility in the event of vascular occlusion. Another benefit is that it can be pre-mixed with local anesthetic, avoiding the need for pre-procedural local anesthetic, which can distort or mask subtle deformities.

The results showed that erythema and swelling were a common observation in the first five days, but generally settled with time; other complications were infrequent. A small number of patients (0.5%) showed signs of vascular occlusion; in most cases, blood flow was restored with simple measures. If not, a hyaluronidase enzyme injection was performed to immediately dissolve the dermal filler. The results lasted for 9-12 months, with approximately 32% returning at 12 months, most of whom were treated again. The study was published the March 2020 issue of Plastic and Reconstructive Surgery.

“The injections are carried out at the radix and move caudally with a micro-droplet technique of boluses of no more than 0.1 mL at any one point. Frequently, and especially nearer the tip, deposits of filler can be as small as 0.02 mL,” concluded Dr. Harb. “With each injection point, the gel implant is massaged into place and can be maneuverer to produce a smooth and symmetrical surface. The injections continue in the midline until the tip is reached; the tip is injected perpendicular to the skin to improve projection and definition.”

Nonsurgical rhinoplasty with injectable dermal fillers has become an increasingly popular alternative to surgical procedures, in view of its relative low cost, convenience and rapid recovery, and low risk profile. Although the procedure is not intended to replace surgical rhinoplasty, it has proven beneficial in discrete cases of inadequate tip projection, dorsal hump, and low radix. Nonsurgical rhinoplasty has also been used to improve functionality of the nose by splinting the nasal valves.


Related Links:
Queen Elizabeth Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.